NF-κB plays a major role during the systemic and local acute inflammatory response following intestinal reperfusion injury

British Journal of Pharmacology

Volumn 145, Issue 2, 2005, Pages 246-254

  Souza, Danielle G ^a   Vieira, Angelica T ^a   Pinho, Vanessa ^a   Sousa, Lirlândia P ^a   Andrade, Anderson A ^a   Bonjardim, Claudio A ^a   McMillan, Michael ^b   Kahn, Michael ^b   Teixeira, Mauro M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

AP 1; IL 10; NF B; Reperfusion injury; TNF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHYL 4 HYDROXY 4 (8 METHYL 1,3 DIOXO 2 PHENYL 2,3,5,8 TETRAHYDRO 1H 1,2,4 TRIAZOLO[1,2 A]PYRIDAZIN 5 YL)BUT 2 YNOATE; MOL 294; N BENZYL 2 (3 CYANOPHENYL) 1,3,7 TRIOXO 2,3,7,8 TETRAHYDRO 1H 1,2,4 TRIAZOLO[1,2 A]PYRIDAZINE 5 CARBOXAMIDE; PNRI 299; PYRIDAZINE DERIVATIVE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; PNRI299; THIOREDOXIN; TRIAZOLE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BLEEDING; BLOOD VESSEL PERMEABILITY; CYTOKINE PRODUCTION; EDEMA; INFLAMMATION; INTESTINE ISCHEMIA; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REPERFUSION INJURY; SUPERIOR MESENTERIC ARTERY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ANIMAL; C57BL MOUSE; DRUG ANTAGONISM; GASTROENTERITIS; INTESTINE; ISCHEMIA; METABOLISM; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSIOLOGY; PROTEIN TRANSPORT; VASCULARIZATION;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; GASTROENTERITIS; INTESTINES; ISCHEMIA; MALE; MESENTERIC ARTERY, SUPERIOR; MICE; MICE, INBRED C57BL; NF-KAPPA B; PROTEIN TRANSPORT; PYRIDAZINES; REPERFUSION INJURY; THIOREDOXIN; TRANSCRIPTION FACTOR AP-1; TRIAZOLES;

EID: 19944404781     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706190     Document Type: Article

References (52)

1. ALMAWI, W.Y. & MELEMEDJIAN, O.K. (2002). Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids. J. Mol. Endocrinol., 28, 69-78.
2. BARNES, P.J. & KARIN, M. (1997). Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med., 336, 1066-1071.
3. BEG, A.A., FINCO, T.S., NANTERMET, P.V. & BALDWIN JR, A.S. (1993). Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol. Cell Biol. 13, 3301-3310.
4. BONJARDIM, C.A. (1997). A mutant cell line partially responsive to both IFN-alpha and IFN-gamma. Braz. J. Med. Biol. Res., 30, 41-50.
5. CARDEN, D.L. & GRANGER, D.N. (2000). Pathophysiology of ischaemia-reperfusion injury. J. Pathol., 90, 255-266.
6. CHEN, L.W., EGAN, L., LI, Z.W., GRETEN, F.R., KAGNOFF, M.F. & KARIN, M. (2003). The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischaemia-reperfusion. Nat. Med., 9, 575-581.
7. CORNEJO, C.J., WINN, R.K. & HARLAN, J.M. (1997). Anti-adhesion therapy. Adv. Pharmacol., 39, 99-142.
8. DIGNAM, J.D., LEBOVITZ, R.M. & ROEDER, R.G. (1983). Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11, 1475-1489.
9. FAN, C., LI, Q., ZHANG, Y., LIU, X., LUO, M., ABBOTT, D., ZHOU, W. & ENGELHARDT, J.F. (2004). IkappaBalpha and IkappaBbeta possess injury context-specific functions that uniquely influence hepatic NF-kappaB induction and inflammation. J. Clin. Invest., 113, 746-755.
10. FUJITA, T., ASAI, T., ANDRASSY, M., STERN, D.M., PINSKY, D.J., ZOU, Y.S., OKADA, M., NAKA, Y., SCHMIDT, A.M. & YAN, S.F. (2004). PKCbeta regulates ischaemia/reperfusion injury in the lung. J. Clin. Invest., 113, 1615-1623.
11. FUNAKOSHI, M., SONODA, Y., TAGO, K., TOMINAGA, S. & KASAHARA, T. (2001). Differential involvement of p38 mitogen-activated protein kinase and phosphatidyl inositol 3-kinase in the IL-1-mediated NF-kappa B and AP-1 activation. Int. Immunopharmacol., 1, 595-604.
12. GILMONT, R.R., DARDANO, A., ENGLE, J.S., ADAMSON, B.S., WELSH, M.J., LI, T., REMICK, D.G., SMITH JR, D.J. & REES, R.S. (1996). TNF-alpha potentiates oxidant and reperfusion-induced endothelial cell injury. J. Surg. Res., 61, 175-182.
13. GHOSH, S. & KARIN, M. (2002). Missing pieces in the NF-kappaB puzzle. Cell, 109, S81-S96.
14. GHOSH, S., MAY, M.J. & KOPP, E.B. (1998). NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol., 16, 225-260.
15. GRANGER, D.N. (1999). Ischaemia-reperfusion: mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease. Microcirculation, 6, 167-178.
16. HIROTA, K., MATSUI, M., IWATA, S., NISHIYAMA, A., MORI, K. & YODOI, J. (1997). AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. U.S.A., 94, 3633-3638.
17. ISHII, M., SUZUKI, Y., TAKESHITA, K., MIYAO, N., KUDO, H., HIRAOKA, R., NISHIO, K., SATO, N., NAOKI, K., AOKI, T. & YAMAGUCHI, K. (2004). Inhibition of c-Jun NH2-terminal kinase activity improves ischaemia/reperfusion injury in rat lungs. J. Immunol., 172, 2569-2577.
18. KHADAROO, R.G., PARODO, J., POWERS, K.A., PAPIA, G., MARSHALL, J.C., KAPUS, A. & ROTSTEIN, O.D. (2003). Oxidant-induced priming of the macrophage involves activation of p38 mitogen-activated protein kinase through an Src-dependent pathway. Surgery, 134, 242-246.
19. KUNSCH, C, LUCHOOMUN, J., GREY, J.Y., OLLIFF, L.K., SAINT, L.B., ARRENDALE, R.F., WASSERMAN, M.A., SAXENA, U. & MEDFORD, R.M. (2004). Selective inhibition of endothelial and monocyte redox-sensitive genes by AGI-1067: a novel antioxidant and anti-inflammatory agent. J. Pharmacol. Exp. Ther., 308, 820-829.
20. LEE, J.I. & BURCKART, G.J. (1998). Nuclear factor kappa B: important transcription factor and therapeutic target. J. Clin. Pharmacol., 38, 981-993.
21. LEFER, A.M. & LEFER, D.J. (1996). The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc. Res., 32, 743-751.
22. LEFER, D.J., FLYNN, D.M. & BUDA, A.J. (1996). Effects of a monoclonal antibody directed against P-selectin after myocardial ischaemia and reperfusion. Am. J. Physiol., 270, H88-H98.
23. LEFLER, S.R., LILLE, ST., HUEMER, G., TUCKER, R., MURRAY, T., SCHOELLER, T. & MULLIGAN, D.C. (2002). Activation time course of activator protein-1 and effect of proline dithiocarbamate during ischaemia-reperfusion in rat skeletal muscle. Ann. Plast. Surg., 49, 654-659.
24. MA, X.L., WEYRICH, A.S., LEFER, D.J., BUERKE, M., ALBERTINE, K.H., KISHIMOTO, T.K. & LEFER, A.M. (1993). Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischaemic reperfused cat myocardium. Circulation, 88, 649-658.
25. MISRA-PRESS, A., MCMILLAN, M., CUDABACK, E., QABAR, M., RUAN, F., NGUYEN, M., VAISAR, T., NAKANISHI, H. & KAHN, M. (2002). Identification of a novel inhibitor of the NF-κB pathway. Curr. Med. Chem.- Anti-inflammatory Anti-Allergy Agents, 1, 29-39.
26. NGUYEN, C, TEO, J.L., MATSUDA, A., EGUCHI, M., CHI, E.Y., HENDERSON JR, W.R. & KAHN, M. (2003). Chemogenomic identification of Ref-1/AP-1 as a therapeutic target for asthma. Proc. Natl. Acad. Sci U.S.A., 100, 1169-1173.
27. OMATA, M., MATSUI, N., INOMATA, N. & OHNO, T. (1997). Protective effects of polysaccharide fucoidin on myocardial ischaemia-reperfusion injury in rats. J. Cardiovasc. Pharmacol., 30, 717-724.
28. ONAI, Y., SUZUKI, J., NISHIWAKI, Y., GOTOH, R., BERENS, K., DIXON, R., YOSHIDA, M., ITO, H. & ISOBE, M. (2003). Blockade of cell adhesion by a small molecule selectin antagonist attenuates myocardial ischaemia/reperfusion injury. Eur. J. Pharmacol., 481, 217-225.
29. PIERCE, J.W., SCHOENLEBER, R., JESMOK, G., BEST, J., MOORE, S.A., COLLINS, T. & GERRITSEN, M.E. (1997). Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem., 272, 21096-21103.
30. POMPERMAYER, K., SOUZA, D.G., LARA, G.G., SILVEIRA, K.D., CASSALI, G.D., ANDRADE, A.A., BONJARDIM, C.A., PASSAGLIO, K.T., ASSREUY, J., CUNHA, F.Q., VIEIRA, M.A.R. & TEIXEIRA, M.M. (2005). The ATP-sensitive potassium channel blocker glibendamide prevents renal ischemia and reperfusion injury in rats. Kidney Int. (in press).
31. PYE, J., ARDESHIRPOUR, F., MCCAIN, A., BELLINGER, D.A., MERRICKS, E., ADAMS, J., ELLIOTT, P.J., PIEN, C., FISCHER, T.H., BALDWIN JR, A.S. & NICHOLS, T.C. (2003). Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury. Am. J. Physiol. Heart Circ. Physiol., 284, H919-H926.
32. QIN, J., CLORE, G.M. & GRONENBORN, A.M. (1996). Ionization equilibria for side-chain carboxyl groups in oxidized and reduced human thioredoxin and in the complex with its target peptide from the transcription factor NF kappa B. Biochemistry, 35, 7-13.
33. RITTER, L.S., COPELAND, J.G. & MCDONAGH, P.F. (1998). Fucoidin reduces coronary microvascular leukocyte accumulation early in reperfusion. Ann. Thorac. Surg., 66, 2063-2072.
34. RUSSELL, J., EPSTEIN, C.J., GRISHAM, M.B., ALEXANDER, J.S., YEH, K.Y. & GRANGER, D.N. (2000). Regulation of E-selectin expression in postischaemic intestinal microvasculature. Am. J. Physiol. Gastrointest. Liver Physiol., 278, G878-G885.
35. SOUZA, D.G., CARA, D.C., CASSALl, G.D., COUTINHO, S.F., SILVEIRA, M.R., ANDRADE, S.P., POOLE, S.P. & TEIXEIRA, M.M. (2000a). Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischaemia of the superior mesenteric artery in the rat. Br. J. Pharmacol., 131, 1800-1808.
36. SOUZA, D.G., CASSALI, G.D., POOLE, S. & TEIXEIRA, M.M. (2001). Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury. Br. J. Pharmacol., 134, 985-994.
37. SOUZA, D.G., COUTINHO, S.F., SILVEIRA, M.R., CARA, D.C. & TEIXEIRA, M.M. (2000b). Effects of a BLT receptor antagonist on local and remote reperfusion injuries after transient ischaemia of the superior mesenteric artery in rats. Eur. J. Pharmacol., 403, 121-128.
38. SOUZA, D.G., GUABIRABA, R., PINHO, V., BRISTOW, A., POOLE, S. & TEIXEIRA, M.M. (2003a). IL-1-driven endogenous IL-10 production protects against the systemic and local acute inflammatory response following intestinal reperfusion injury. J. Immunol., 170, 4759-4766.
39. SOUZA, D.G., LOMEZ, E.S., PINHO, V., PESQUERO, J.B., BADER, M., PESQUERO, J.L. & TEIXEIRA, M.M. (2004a). Role of bradykinin B2 and B1 receptors in the local, remote, and systemic inflammatory responses that follow intestinal ischaemia and reperfusion injury. J. Immunol., 172, 2542-2548.
40. SOUZA, D.G., PINHO, V., PESQUERO, J.L., LOMEZ, E.S., POOLE, S., JULIANO, L., CORREA JR, A., DE, A., CASTRO, M.S. & TEIXEIRA, M.M. (2003c). Role of the bradykinin B2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury. Br. J. Pharmacol., 139, 129-139.
41. SOUZA, D.G., PINHO, V., SOARES, A.C., SHIMIZU, T., ISHII, S. & TEIXEIRA, M.M. (2003b). Role of PAF receptors during intestinal ischaemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment. Br. J. Pharmacol., 139, 733-740.
42. SOUZA, D.G., SOARES, A.C., PINHO, V., TORLONI, H., REIS, L.F., TEIXEIRA, M.M. & DIAS, A.A. (2002). Increased mortality and inflammation in tumor necrosis factor-stimulated gene-14 transgenic mice after ischaemia and reperfusion injury. Am. J. Pathol., 160, 1755-1765.
43. SOUZA, D.G., VIEIRA, A.T., SOARES, A.C., PINHO, V., NICOLI, J.R., VIEIRA, L.Q. & TEIXEIRA, M.M. (2004b). The essential role of the intestinal microbiota in facilitating acute inflammatory responses. J. Immunol., 173, 4137-4146.
44. TAKADA, Y., SINGH, S. & AGGARWAL, B.B. (2004). Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis. J. Biol. Chem., 279, 15096-15104.
45. TAKEUCHI, D., YOSHIDOME, H., KATO, A., ITO, H., KIMURA, F., SHIMIZU, H., OHTSUKA, M., MORITA, Y. & MIYAZAKI, M. (2004). Interleukin 18 causes hepatic ischaemia/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice. Hepatology, 39, 699-710.
46. TEGEDER, I., NIEDERBERGER, E., ISRAR, E., GUHRING, H., BRUNE, K., EUCHENHOFER, C, GROSCH, S. & GEISSLINGER, G. (2001). Inhibition of NF-kappaB and AP-1 activation by R- and 5-flurbiprofen. FASEB J., 15, 595-597.
47. XANTHOUDAKIS, S. & CURRAN, T. (1992). Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J., 11, 653-665.
48. ZINGARELLI, B., HAKE, P.W., O'CONNOR, M., DENENBERG, A., WONG, H.R., KONG, S. & ARONOW, B.J. (2004). Differential regulation of activator protein-1 and heat shock factor-1 in myocardial ischaemia and reperfusion injury: role of poly(ADP-ribose) polymerase-1. Am. J. Physiol. Heart Circ. Physiol., 286, H1408-H1415.
49. ZINGARELLI, B., SHEEHAN, M. & WONG, H.R. (2003). Nuclear factor-kappaB as a therapeutic target in critical care medicine. Crit. Care Med., 31, S105-S111.
50. ZOU, L., ATTUWAYBI, B. & KONE, B.C. (2003). Effects of NF-kappa B inhibition on mesenteric ischaemia-reperfusion injury. Am. J. Physiol. Gastrointest. Liver Physiol., 284, G713-G721.
51. WILLERSON, J.T. (1997). Pharmacologic approaches to reperfusion injury. Adv. Pharmacol., 39, 291-312.
52. YEH, K.Y., YEH, M., GLASS, J. & GRANGER, D.N. (2000). Rapid activation of NF-kappaB and AP-1 and target gene expression in postischaemic rat intestine. Gastroenterology, 118, 525-534.